Jeffrey T. Walsh
2017
In 2017, Jeffrey T. Walsh earned a total compensation of $4.8M as Chief Financial and Strategy Officer at bluebird bio, a 55% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $250,600 |
|---|---|
| Option Awards | $3,012,038 |
| Salary | $425,000 |
| Stock Awards | $1,103,760 |
| Other | $12,000 |
| Total | $4,803,398 |
Walsh received $3M in option awards, accounting for 63% of the total pay in 2017.
Walsh also received $250.6K in non-equity incentive plan, $425K in salary, $1.1M in stock awards and $12K in other compensation.
Rankings
In 2017, Jeffrey T. Walsh's compensation ranked 2,004th out of 14,666 executives tracked by ExecPay. In other words, Walsh earned more than 86.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,004 out of 14,666 | 86th |
Division Manufacturing | 681 out of 5,770 | 88th |
Major group Chemicals And Allied Products | 181 out of 2,074 | 91st |
Industry group Drugs | 134 out of 1,730 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 29 out of 316 | 91st |
Source: SEC filing on April 27, 2018.
Walsh's colleagues
We found four more compensation records of executives who worked with Jeffrey T. Walsh at bluebird bio in 2017.